Dr. Greater Kayode Oyejobi is a researcher in the field of microbiology. He obtained his PhD from the Wuhan Institute of Virology, Chinese Academy of Sciences. He is currently a postdoc at Wuhan University. His current research focuses on bacteriophage-bacterial coevolutionary dynamics. He is studying antiphage defense systems in bacteria, alongside counter-defense pathways in phages, in view of informing the design and implementation of phage therapy.

N/A

Piotr Sliz is a structural biologist with expertise in non-coding RNA regulation, and an Associate Professor in Pediatrics, Biological Chemistry and Molecular Pharmacology at Harvard Medical School. He has been leading research computing at Boston Children’s Hospital since 2016. He received his Ph.D. in Biochemistry from the University of Toronto in 2000. Some BCH-wide programs developed under his leadership include Pediatric Scholar, Children’s Rare-Disease Cohorts genomic data initiative, bioinformatics and genomics consulting services, and a Longwood-wide CryoEM computing effort. He also founded and leads SBGrid—a global structural bioinformatics consortium. He is affiliated with the Manton Center for Orphan Disease Research.

Longfei Wang is a Professor at the School of Pharmaceutical Sciences, Faculty of Medical Sciences, Wuhan University, Wuhan, China. He graduated with a B.S. in Biotechnology from Huazhong Agricultural University in 2005 and obtained his Ph.D. in Biochemistry and Molecular Biology from the Institute of Biophysics, Chinese Academy of Sciences in 2011. After graduation, he worked as a postdoctoral research fellow at the Harvard Medical School from October 2011 to April 2017. Subsequently, he worked as a lecturer at the Boston Children's Hospital, Harvard Medical School from April 2017 to July 2021. His research interests lie in the areas of molecular immunology and structural pharmacology. His research topics include elucidating the molecular mechanism of host cell defense against pathogens, investigating the structural basis of signaling in immune cell surface receptors and developing small molecules and biomolecules (antibodies, peptides, nucleic acids, etc.) that can be used to regulate immune signaling pathways. He has authored/co-authored more than 20 publications in international peer-reviewed journals and holds an international patent.